Nimbolide-based nanomedicine inhibits breast cancer stem-like cells by epigenetic reprogramming of DNMTs-SFRP1-Wnt/β-catenin signaling axis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nimbolide-based nanomedicine inhibits breast cancer stem-like cells by epigenetic reprogramming of DNMTs-SFRP1-Wnt/β-catenin signaling axis

Published:2023-12 Issue: Volume:34 Page:102031
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Mohapatra Priyanka,Madhulika Swati,Behera Somalisa,Singh Priya,Sa Pratikshya,Prasad Punit,Swain Rajeeb Kumar,Sahoo Sanjeeb Kumar

Funder

Department of Science and Technology, Ministry of Science and Technology, India

Life Sciences Institute

Department of Biotechnology, Ministry of Science and Technology, India

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference64 articles.

1. Treatment landscape of triple-negative breast cancer - expanded options, evolving needs;Bianchini;Nat. Rev. Clin. Oncol.,2022

2. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease;Bianchini;Nat. Rev. Clin. Oncol.,2016

3. The Breast Cancer Stem Cells Traits and Drug Resistance;Zheng;Front. Pharmacol.,2020

4. Piperlongumine loaded PLGA nanoparticles inhibit cancer stem-like cells through modulation of STAT3 in mammosphere model of triple negative breast cancer;Singh;Int. J. Pharm.,2022

5. Reprogramming Cancer Stem-like Cells with Nanoforskolin Enhances the Efficacy of Paclitaxel in Targeting Breast Cancer;Singh;ACS Appl. Bio Mater.,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Why Is Wnt/β-Catenin Not Yet Targeted in Routine Cancer Care?;Pharmaceuticals;2024-07-16

2. Comment l’activité physique pourrait-elle réduire le risque de survenue et de récidive des cancers du sein ?;Gynécologie Obstétrique Fertilité & Sénologie ;2024-03

3. Overexpression of URG11 can inhibit the proliferation and motility of breast cancer cells;European Journal of Gynaecological Oncology;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3